Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
SIB Swiss Institute of Bioinformatics | RCV001731256 | SCV002500953 | likely pathogenic | Joubert syndrome 40 | 2022-04-20 | criteria provided, single submitter | curation | This variant is interpreted as likely pathogenic for Joubert syndrome 40, autosomal recessive. The following ACMG Tag(s) were applied: Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium (PM2); Predicted nullvariant in a gene where LOF is a known mechanism of disease (PVS1 downgraded to strong). |
Labcorp Genetics |
RCV002539803 | SCV003008600 | pathogenic | not provided | 2022-07-23 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1300253). This premature translational stop signal has been observed in individual(s) with Joubert syndrome (PMID: 34539760). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.006%). This sequence change creates a premature translational stop signal (p.Glu285*) in the IFT74 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFT74 are known to be pathogenic (PMID: 33531668). |
OMIM | RCV001731256 | SCV001981700 | pathogenic | Joubert syndrome 40 | 2021-10-21 | no assertion criteria provided | literature only |